Medicine | Penn Today

The race to make a vaccine for breast cancer

Robert Vonderheide of the Abramson Cancer Center at the Perelman School of Medicine talks about his work on a vaccine to prevent cancers for the rest of people’s lives.

A person holds a sign during a protest that reads WELL INFORMED NOT CONSENTING.

Misinformation about vaccine safety drives reluctance to vaccinate children

While 78% of U.S. adults are vaccinated against COVID-19, only 31% of children have been vaccinated. The discrepancy points to the acceptance of misinformation about the safety of vaccines in general and the COVID-19 vaccines in particular, according to a new study.

Pregnancy, childbirth, the pandemic, and stress

For two years, the interdisciplinary Project IGNITE has followed 1,000 pregnant individuals and their children to learn more about what role environmental factors play in preterm birth, poor pregnancy outcomes, and social and emotional development.

New potential drug treatment for Alzheimer’s disease has Pa. patients, advocates, and doctors hopeful

Jason Karlawish of the Perelman School of Medicine says that the results for new Alzheimer’s drug lecanemab look promising, complimenting the representative diversity of clinical trials.

Misinformation drives low child COVID vaccination rates, Penn study finds

A new study from the Annenberg Public Policy Center finds that fears of COVID vaccines are influencing parents’ decisions not to vaccinate their children, featuring a quote from Dan Romer.

How can the latest Alzheimer’s therapy reach patients? Follow this trustworthy process

In an op-ed, Jason Karlawish of the Perelman School of Medicine outlines the reliable process required to properly evaluate the effects of lecanemab, a new Alzheimer’s drug already approved by the FDA.

Why you should be worried about the Supreme Court

PIK Professor Dorothy Roberts appears on an episode of “System Error” to explain how the overturning of Roe v. Wade has impacted and disenfranchised women, particularly Black women.

Biogen’s next Alzheimer drug feeds push for FDA approval revamp

Emily Largent and Holly Fernandez Lynch of the Perelman School of Medicine are quoted about the clinical uncertainty of new Alzheimer’s drug findings and the FDA’s need to have post-approval trials underway.

Five women who should have won a Nobel Prize

Katalin Karikó of the Perelman School of Medicine is lauded for her work with Perelman’s Drew Weissman pioneering the use of synthetic messenger RNA to fight diseases, which served as the basis for two widely used COVID-19 vaccines.

How health systems can truly value Black lives: Help close the racial wealth gap

In an op-ed, the Perelman School of Medicine’s Atheendar Venkataramani, Eugenia C. South, and George Dalembert, also of the Children’s Hospital of Philadelphia, write that health systems are uniquely positioned as economic engines to address the racial wealth gap.

Filters